Background: As part of the EuroDRG project, researchers from eleven countries (i.e. Austria, England, Estonia, Finland, France, Germany, Ireland, Netherlands, Poland, Sweden, and Spain) compared how their Diagnosis-Related Groups (DRG) systems deal with cholecystectomy patients. The study aims to assist surgeons and national authorities to optimize their DRG systems. Methods: National or regional databases were used to identify hospital cases with a procedure of cholecystectomy. DRG classification algorithms and indicators of resource consumption were compared for those DRGs that individually contained at least 1% of cases. Six standardised case vignettes were defined, and quasi prices according to national DRG-based hospital payment systems were ascertained and compared to an index case. Results: European DRG systems vary widely: they classify cholecystectomy patients according to different sets of variables into diverging numbers of DRGs (between two DRGs in Austria and Poland to nine DRGs in England). The most complex DRG is valued at four times more resource intensive than the index case in Ireland but only 1.3 times more resource intensive than the index case in Austria. Conclusion: Large variations in the classification of cholecystectomy patients raise concerns whether all systems rely on the most appropriate classification variables. Surgeons, hospital managers and national DRG authorities should consider how other countries' DRG systems classify cholecystectomy patients in order to optimize their DRG systems and to ensure fair and appropriate reimbursement. Implications for policy makers • The result of this study can help policy-makers to consider alternative and possibly better ways to classify their patients into DiagnosisRelated Groups (DRG).
Introduction
Gallbladder surgery is one of the most frequent major surgeries in general surgery departments (1) and a cholecystectomy procedure is considered a benchmark procedure for a surgeon and surgical department (due to high prevalence, relevant impact on the population's health, high clinical variability, and substantial use of resources) (2, 3) . Diagnosis-Related Groups (DRGs) are Patient Classification Systems (PCSs), which are commonly used to classify, benchmark and ultimately pay for hospital treatment (4) . In current DRG-type hospital payment systems, DRGs define the payment categories, i.e. hospital products (4) . As such, they are designed to increase the transparency about the services and provide incentives for the efficient use of resources within hospitals (4) . Another type of standardized agreement in healthcare are clinical guidelines, which are also used for guiding decisions and criteria regarding diagnosis, management and treatment, and are increasingly used as benchmarks for high quality care. It is important that management tools, which provide administrative incentives for clinical decision-making, are coherent. All the above also applies to Episodes of Care (EoC) 1 , such as cholecystectomy. Classifications in healthcare are needed to transform information about human health and medical interventions to facilitate aggregation, analysis, decision-making and learning among people, and increasingly between software agents (5) . A well-designed classification system that is serving as the basis for a fair hospital payment or as the basis of performance comparisons should assure homogenous groups of patients based on most important determinants of resource consumption as classification variables and do so in a systematic manner (6) . Otherwise, DRGs do not adequately control for differences of patients within different groups and reimbursement or benchmarking for some patient groups will not be adequate (4) . It is also possible that if the PCS that is used for payment and benchmarking purposes is performing inadequately, it creates a potential conflict of incentives for clinical professionals and managers (7, 8) . DRG systems usually group treatment cases on the basis of classification variables such as diagnoses, procedures and demographic characteristics. However, DRG systems in different countries and sometimes even within countries vary a lot, and they are in a constant state of evolving (4) . Very often professional specialist experts or consultants formally participate in the process of selection, definition, and update of classification criteria for respective DRGs (9) . Thus, it is of utmost importance both for specialist groups such as surgeons as well as hospital managers to be aware of how their respective patients are classified by their DRG system in order to assess whether the classification variables adequately reflect differences in the complexity of treating different groups of patients using different techniques.
Comparison of different countries' DRG systems classification principles can help surgeons to identify potential scope for improvement of their system or find cross-country agreement in classification principles in the same manner and direction as clinical guidelines. Also, analysing the different approaches to assigning a value and reimbursement tag for similar patients in other DRG systems may inform and support discussions about the adequacy of the existing practice. To the best of our knowledge, detailed comparative analyses of classification algorithms for cholecystectomy are very scarce, suffer from a very limited scope, and have not assessed the classification of patients using routine inpatient data (10) . Overall, studies across Europe suggest DRG-based payment systems have been associated with reduction in unit costs but also with an increase in total cost, due in part, to increased activity (4) . Whether this has improved system efficiency depends on a number of factors, including: the impact on quality; the 'value' of the additional activity in terms of health gain; and whether there was cost-shifting (for example, with greater costs being borne in community and primary care from earlier discharge for patients) and gaming of the system 1. The EoCs are uniformly defined across countries through diagnosis and/or procedure codes and can be understood as 'meta-DRGs' which encompass varying numbers of actual DRGs within countries.
(through up-coding and patient selection). Very few studies have examined the impact of payments based on DRGs on system-wide efficiency (11) . For hospital care, case-mix adjusted bundled payments are well established across Europe and are being expanded to cover more types of inpatient care. While having had an impact in Europe, with respect to increasing activity and reducing Length of Stay (LOS), DRG-type payments may not alone help to improve the quality of care (particularly the coordination of care for patients beyond hospital settings), or control overall costs of hospital care (11) . This study therefore performs a comprehensive assessment of DRG systems across eleven European countries and has three main objectives: 1) to assess classification variables and algorithms used to group patients with cholecystectomy into DRGs; 2) to compare the composition of these DRGs and variations in relative resource intensity; and 3) to determine DRGs and hospital price levels for six case vignettes of cholecystectomy patients with different combinations of demographic, diagnostic and treatment variables. The results were generated in the framework of the EuroDRG project (4), which selected ten episodes of care to assess European DRG systems and their ability to define homogenous groups of patients. In this article, we focus on cholecystectomy as it is one of the most common emergency surgical procedures in high-income countries (12) (13) (14) .
Methods

Definition of episode of care and cholecystectomy index case
A common definition for a cholecystectomy EoC was agreed as part of the EuroDRG project by researchers from eleven European countries (i.e. Austria, England, Estonia, Finland, France, Germany, Ireland, the Netherlands, Poland, Spain, and Sweden). The definition was based on the International Classification of Diseases 10 th edition (ICD-10) for diagnoses and ICD-9 Clinical Modification (ICD-9CM) for procedures and is presented in Box 1. Researchers from each country translated the definition into national codes for diagnoses and procedures considering available mappings from the Hospital Data Project if applicable (15) . Similar methods have been reported for another episode of care (16) (17) (18) (19) (20) (21) (25) . In addition, a quasi-price index was calculated with the index case assuming a value of one. The index score of all other case vignettes was calculated by dividing the monetary value of the quasi price (10) of each case vignette by that of the index case. 
Results
Patient classification of cholecystectomy cases in Europe
The figure shows large differences in the DRG systems for the 
Distribution of cholecystectomy cases and variation in relative resource intensity
In most countries, the vast majority of cholecystectomy EoC cases are grouped into the shadowed DRG (in Figure 1 ) containing the index case (see Box 1), i.e. between 55% in Finland and 92% in Austria. Within these index DRGs, almost all patients conform to our EoC definition (i.e. around 90% or above). The cost index shows that the index DRG is the lowest valued DRG only in Poland, England, Estonia and Spain (see Figure 2 ). Generally, in DRG systems with only three or four DRGs for cholecystectomy patients, even the highest valued DRG has the cost the index below two. The low variation cost index values compared to index case could be an indication of differences in coding practices across countries or poor quality data. The lowest variation in DRG weight index scores exists in Austria, Germany, Poland and Netherlands with a range of about one. In these countries, but also in England, Finland, Sweden and France, indicating that the systems do not systematically account for cases that are more than twice as resource intensive as the index case. In contrast, the range of DRG weight index scores is considerably higher in Ireland (0.4-4.0) (see Figure 2) . Table 3 shows a comparison of DRGs and hospital quasi prices, reflecting national average hospital payments for each case vignette under the assumption that hospital payment would be exclusively based on DRGs. For each case vignette, the first column specifies the DRG into which a patient would be classified and whether he or she would be considered an inlier or an outlier, i.e. whether the predefined length of stay is above or below the DRG system specific upper or lower length of stay threshold. The second column specifies the corresponding quasi price for each patient. In the last column of the table, the index DRGs (see Figure 1 ) and corresponding quasi prices are presented.
Diagnosis-Related Groups (DRGs) and hospital quasi prices for case vignettes
Apparently, large variation in hospital payments exists across countries. Index case forms the majority of total cases. Index case is generally a patient with milder condition, without comorbidities. However it is observed that only for Estonia, England, Poland and Spain the payment for index case is lower than for other patient groups. Cases with lower payments are mostly found in patient group 5 (day-care laparoscopic without CC 
Discussion
This is the most comprehensive available comparative analysis of grouping algorithms, classification variables, and prices for cholecystectomy patients in different DRG-based hospital payment systems in Europe. It shows great variation across countries: 1) in the number of DRGs; 2) in the characteristics of classification variables; 3) in the degree of differentiation between complex and less complex cases; and 4) in the quasi prices for different types of patients (case vignettes). If DRG systems do not adequately account for differences among patients, hospitals and surgeons that treat a greater share of more complex cases are not adequately compensated for their greater efforts. Possibly, in countries with only a few DRGs in order to account for differences in complexity, some of the variations in patient populations among hospitals are accounted for through adjustments (e.g. for teaching status or type of hospital) outside of the DRG systems (9). However, ideally, differences in patient characteristics would be accounted for in the PCS and not in the payment system. The implementation of DRGs also raises several other issues. In particular, the same clinical situation should be approached in an uniform way, but different systems of incentive-based funding may induce a potential conflict of interest for a doctor. In the worst case, the financial incentives could lead to treatments that are clinically inappropriate and to differences in DRG coding motivated by those incentives (29) . Moreover, it does not come out from the study what are the reasons behind the fact that the same clinical situations are priced differently in comparison to the index case. Also, the question arises as to what extent the other factors are reflected in the DRG cost. In most countries the co-morbidities and complications are taken into account in DRGs but their influence on DRG cost is most probably not uniform. Thus, the question arises as to how much the co-morbidities affect the actual prices. The DRG system may be observed in several aspects. First, their logic is not always the same, even though there is consensus about treatment. Technically, DRGs need to be based on both economically and clinically meaningful groups. That requires careful decisions on the design of the DRG system, such as the hierarchy and algorithms used to classify patients into a limited number of groups. Economically, patients within one group Shadow prices were calculated by multiplying cost weights with the national base rates. In actual reimbursement, hospitals are paid through a mix of DRG based reimbursement and fee-for-service. The actual DRG based reimbursement is only 70% of the reported shadow price with the remaining 30% being related to fee-for-service payments. In some hospital districts, patient 3 might be considered an outlier. In this case certain surcharges based on per diems might be applied.
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Reported prices are for public sector hospitals since private hospital prices do not reflect full costs.
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Calculated using national DRG cost weights and the average of state-wide base rates. should have homogeneous costs. Clinically, cases allocated to one group should form a distinguishable entity based on main diagnosis, severity, co-morbidity and/or treatment performed. But what exactly is homogeneous? When are costs and/or clinical diagnosis so different that a group should be split? (30) . Second, DRGs are put together electronically on the basis of input data. Since an electronic format is used, there is a risk that a lack of data may cause conflicts (administrative side, money, information, treatment algorithms, etc.). Thus, the question arises whether the DRG system still takes into account all the needs. Administrators of a DRG system adjust rules for split, fusion or other changes in DRGs. DRGs should be put together according to common guidelines, to ensure its safety, transparency and, immunity against manipulations. In drawing meaningful conclusions from this study, it is important to be cognisant of its limitations, especially in relation to the ability to undertake direct cross-country comparisons. First, although there was an agreed definition for cholecystectomy, relevant cases in each country were identified using a different procedure and (to a lesser extent) diagnosis coding schemes. In the absence of a common procedure classification system [such as the World Health Organization (WHO) has developed for diagnoses], there is a considerable cross-country divergence in the schemes implemented. Second, coding practice differs across countries. There is variation in coding depth: the maximum number of diagnoses used in DRG assignment is ten in Finland, but 120 in Germany. Furthermore, the propensity to record diagnoses and procedures may be related to whether the DRG system is used in hospital reimbursement.
Limitations
Our study has several limitations. Firstly, the data used to identify patients and to assess the relative importance of different DRGs in different countries, originated from routine inpatient databases in eleven countries (see Table 1 ). Although the data can be compared, it must be taken into account the fact that countries have different coding practices and the quality may not be entirely comparable. Secondly, countries have different payment systems for hospitals, and consequently make the payment levels difficult to compare (see Table 3 ). On the one hand, countries set DRGbased payment rates at varying levels as they include different cost categories. For example, in Germany, fixed capital costs are not included in DRG-based payment, whereas in most other countries, DRG-based payments are supposed to cover capital costs (10) . Different systems of additional payments exist, e.g. England assigns additional Health Resource Groups (HRGs) for certain diagnostic evaluations, such as CT scans; Poland and Austria have additional per-diem based payments for stays in intensive care units (23) . Furthermore, in the Dutch and the Finnish DRG systems several DRGs per hospital stay can be assigned, each leading to additional DRGbased payments (4). DRG-based payments are adjusted in several countries to account for differences among hospitals or regions. Therefore, the absolute price levels should not be directly interpreted as reflecting more expensive care in one country compared to another. However, relative price levels within countries that were used for comparisons in Figure 2 should be less affected by differences in payment systems as they were always compared to the in-country DRG index case. Thirdly, as we limit part of our comparative analysis to DRGs that account for at least 1% of cases (Figure 1 ), we partially neglect how different systems deal with rare outliers, which may, however, be particularly relevant for reimbursement (31) . In addition, there is one more limitation in this study; it is possible that some patients were inappropriately coded in order to maximize revenues ("up-coding"). Despite these limitations, our study has major implications for surgeons, hospital managers and national authorities involved in the redesigning of national DRG systems. First, awareness about classification algorithms and variables in other countries should encourage surgeons to think about alternative and possibly better ways to classify their patients into DRGs. For example, three countries (Austria, the Netherlands and Germany) do not distinguish between cholecystectomy cases with complications. The average length of stay is taken into account only in the French DRG system, although it greatly affects the price of a cholecystectomy episode. The price index of patient groups 4 (day-care laparoscopic with CC) and 5 (day-care laparoscopic without CC) is lower (<1) for patients in France, Germany, Ireland, Netherlands and Sweden (see Figure 2 ). Seven countries (except Austria, England, Poland and France) differentiate between open and laparoscopic cholecystectomy, which is a very important measure for differentiating patients with an episode of cholecystectomy. Second, DRG systems are meant to provide precise measures of the kind of services hospitals deliver. This measure is useful only if DRGs describe a sufficiently homogenous group of patients (30) . Therefore, quantitative research is needed to verify whether the most important determinants of cost are considered in different PCSs, and whether differences among systems reflect country specific differences in treatment patterns. However, it is also important for clinicians to be aware of the significance of adequately designed DRG systems and to engage in optimizing these systems. Information presented in this article about how DRG systems classify cholecystectomy patients can help surgeons engage with national DRG authorities. In the light of increasing pressure for cost containment, it is very important that DRG systems consider the most important classification variables in order to ensure that limited resources are appropriately allocated for patients undergoing cholecystectomy.
Conclusion
The present survey shows that the DRG systems can be compared, even though there are many limiting factors, arising from the particular national characteristics. These international comparisons can provide a very useful new perspective especially when governments, Ministries of Health or payers are investigating how to improve an existing DRG system. These researches can also allow countries, which are introducing DRG system, to avoid making gross errors or mistakes in composing their DRG system.
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